MabVax Therapeutics Holdings, Inc. filed a motion in the US Bankruptcy Court seeking the extension of its exclusivity periods on July 10, 2019. As per the motion, the debtor seeks to extend its exclusivity periods for both, to file a plan and to solicit votes on a plan, by 120 days i.e. up to November 18, 2019 and January 17, 2020, respectively.